PFE +5% on initial COVID-19-vaccine data: https://endpts.com/pfizer-shares-surge-on-positive-impact-of-their-mrna-covid-19-vaccine-partnered-with-biontech-in-an-early-stage-study/ Curiously, PFE’s partner on this program, BNTX, is up only 3% as I’m typing.